Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Brensocatib by Insmed for Hidradenitis Suppurativa: Likelihood of Approval
Brensocatib is under clinical development by Insmed and currently in Phase I for Hidradenitis Suppurativa. According to GlobalData, Phase I...
Brensocatib by Insmed for Bronchiectasis: Likelihood of Approval
Brensocatib is under clinical development by Insmed and currently in Phase III for Bronchiectasis. According to GlobalData, Phase III drugs...
Brensocatib by Insmed for Hidradenitis Suppurativa: Likelihood of Approval
Brensocatib is under clinical development by Insmed and currently in Phase I for Hidradenitis Suppurativa. According to GlobalData, Phase I...